Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Connect Biopharma Holdings (CNTB) Share-based Compensation (2024 - 2025)

Connect Biopharma Holdings (CNTB) has disclosed Share-based Compensation for 2 consecutive years, with $917000.0 as the latest value for Q4 2025.

  • Quarterly Share-based Compensation fell 34.55% to $917000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.7 million through Dec 2025, down 44.62% year-over-year, with the annual reading at $3.7 million for FY2025, 44.62% down from the prior year.
  • Share-based Compensation hit $917000.0 in Q4 2025 for Connect Biopharma Holdings, roughly flat from $916000.0 in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $2.0 million in Q3 2024 to a low of $916000.0 in Q3 2025.